The decays of B mesons to a pair of charmless pseudoscalar (P ) mesons are analyzed within a framework of flavor SU(3). Symmetry breaking is taken into account in tree (T ) amplitudes through ratios of decay constants; exact SU(3) is assumed elsewhere. Acceptable fits to B → ππ and B → Kπ branching ratios and CP asymmetries are obtained with tree, color-suppressed (C), penguin (P ), and electroweak penguin (P EW ) amplitudes. Crucial additional terms for describing processes involving η and η ′ include a large flavor-singlet penguin amplitude (S) as proposed earlier and a penguin amplitude P tu associated with intermediate t and u quarks. For the B + → π + η ′ mode a term S tu associated with intermediate t and u quarks also may be needed. Values of the weak phase γ are obtained consistent with an earlier analysis of B → V P decays, where V denotes a vector meson, and with other analyses of CKM parameters.
We study the effects of an extra U(1) gauge boson with flavor changing couplings with fermion mass eigenstates on certain B meson decays that are sensitive to such new physics contributions. In particular, we examine to what extent the current data on B d → φK and B d → η K decays may be explained in such models, concentrating on the example in which the flavor changing couplings are left-chiral. We find that within reasonable ranges of parameters, the Z contribution can readily account for the anomaly in S φK S but is not sufficient to explain large branching ratio of B d → η K with the same parameter value. S φK S and S η K S are seen to be the dominant observables that constrain the extra weak phase in the model.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.